Rennova Health Inc
(RNVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 3,843 | 3,538 | 6,389 | 4,916 | 5,460 |
| Cost of Goods | 2,081 | 1,807 | 1,834 | 1,853 | 1,998 |
| Gross Profit | 1,762 | 1,732 | 4,555 | 3,063 | 3,461 |
| Operating Expenses | 2,725 | 3,139 | 3,292 | 3,164 | 3,071 |
| Operating Income | -882 | -601 | 2,097 | 752 | 1,388 |
| Interest Expense | 49 | 421 | 432 | 552 | 552 |
| Other Income | -1,251 | 282 | 136 | 606 | 232 |
| Pre-tax Income | -2,182 | -740 | 1,802 | 806 | 1,069 |
| Income Tax | -93 | -185 | 517 | N/A | N/A |
| Net Income Continuous | -2,089 | -555 | 1,285 | 806 | 756 |
| Net Income Discontinuous | -7,186 | -1 | -8 | N/A | 64 |
| Minority Interests | -11 | -8 | -1 | N/A | N/A |
| Net Income | $-9,264 | $-548 | $1,278 | $806 | $820 |
| EPS Basic Total Ops | N/A | 0.00 | 0.00 | 0.00 | 28.79 |
| EPS Basic Continuous Ops | N/A | 0.00 | 0.00 | 0.00 | 28.79 |
| EPS Diluted Total Ops | N/A | 0.00 | 0.00 | 0.00 | 28.79 |
| EPS Diluted Continuous Ops | N/A | 0.00 | 0.00 | 0.00 | 28.79 |
| EBITDA(a) | $-822 | $-544 | $2,196 | $846 | $1,556 |